Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Suggested specifications for a standardized Addiction Severity Index database.

D Carise1, A T McLellan, J Cacciola

  • 1The Treatment Research Institute, The University of Pennsylvania, Philadelphia, PA, USA. dcarise@tresearch.org

Journal of Substance Abuse Treatment
|August 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

NAP7 and airway management: as important as life and death.

Anaesthesia·2024
Same author

Addressing human factors is crucial to preventing unrecognised oesophageal intubation.

Anaesthesia·2022
Same author

Clinical examination may increase but not decrease suspicion of oesophageal intubation.

Anaesthesia·2022
Same author

Canadian Surgery Forum.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

AXIOS STENTS: TRANSFORMING THE MANAGEMENT OF PANCREATIC FLUID COLLECTIONS.

The Ulster medical journal·2021
Same author

Sample preparation with sucrose cryoprotection dramatically alters Zn distribution in the rodent hippocampus, as revealed by elemental mapping.

Journal of analytical atomic spectrometry·2021
Same journal

Call for commentaries on COVID-19.

Journal of substance abuse treatment·2024
Same journal

TOC (update).

Journal of substance abuse treatment·2023
Same journal

TOC (update).

Journal of substance abuse treatment·2023
Same journal

TOC (update).

Journal of substance abuse treatment·2023
Same journal

A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.

Journal of substance abuse treatment·2022
Same journal

Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing.

Journal of substance abuse treatment·2022
See all related articles

This study introduces a Standard Addiction Severity Index (ASI) Database to improve data sharing. A standardized format will enhance the value of ASI data for clinicians, researchers, and policymakers.

Area of Science:

  • Addiction research
  • Health informatics
  • Data standardization

Background:

  • The Addiction Severity Index (ASI) is a widely used tool in addiction studies.
  • Multiple ASI versions and data systems hinder data sharing and reduce information value.
  • Difficulty in sharing ASI data limits its utility for treatment providers, policymakers, and researchers.

Purpose of the Study:

  • To establish operational definitions and specifications for a Standard ASI Database.
  • To create a unified format for collecting and storing ASI data.
  • To facilitate seamless data sharing across different users and systems.

Main Methods:

  • Developed standard variable names, data types, field lengths, value labels, and range checks for the ASI, 5th edition.

Related Experiment Videos

  • Provided electronic access to detailed specifications.
  • Illustrated examples and rationale for the standard database elements.

    • Main Results:

    • Defined specifications for a "Standard ASI Database."
    • Included details on variable names, data types, field lengths, value labels, and range checks.
    • Made comprehensive ASI data elements available electronically.

    Conclusions:

    • A Standard ASI Database format is proposed to become an industry standard.
    • Standardization will enable easier data sharing regardless of software or collection methods.
    • This will significantly benefit treatment providers, clinicians, researchers, payers, and policymakers.